Rapid Strep Testing: Predictive Values and a Proposed Policy Change
A school-based health center offers a rapid antigen test for group A streptococcal pharyngitis. During a 3-month period, 300 children with sore throat are tested; 90 have a positive throat culture used as the reference standard. The rapid test has a sensitivity of 92% and a specificity of 96% in this population. A parent whose child has a positive rapid test asks whether the result means the child definitely has strep throat and needs antibiotics. The nurse manager is also considering a policy to skip backup culture for all negative rapid tests to save money and reduce return visits. The center serves many families with limited transportation and high rates of untreated strep in the community. The test costs $12; culture costs $18; the center has no extra staffing.
1. Calculate and interpret the positive and negative predictive values for this population.
Read the worked answer
Prevalence = 90/300 = 30%. With sensitivity 92%, true positives = 0.92 × 90 = 82.8, and false negatives = 7.2. With specificity 96%, false positives = 0.04 × 210 = 8.4, and true negatives = 201.6. Using rounded counts: TP 83, FN 7, FP 8, TN 202.
PPV = TP/(TP+FP) = 83/(83+8) = 83/91 ≈ 91.2%. NPV = TN/(TN+FN) = 202/(202+7) = 202/209 ≈ 96.7%. So a positive rapid test has about a 91% chance of true strep in this population; a negative test has about a 97% chance of no strep. The predictive values depend on the 30% prevalence; in a lower-prevalence population, the same sensitivity and specificity would yield a lower PPV and a higher NPV. This is why the center should interpret results in the local context and with clinical findings.
2. A parent asks whether a positive rapid test means the child definitely has strep throat and must take antibiotics. Explain how you would respond.
Read the worked answer
Start by explaining that the rapid test is very helpful but not perfect. A positive result means the child probably has strep-about 91 out of 100 positive tests are true positives in this population-but it does not prove it with certainty. Some positive results are false positives, and some children may be carriers. The decision to treat should combine the test with symptoms and signs: fever, tonsillar exudate, tender anterior cervical nodes, and absence of cough increase the likelihood of true infection.
If the child has typical symptoms and a positive rapid test, antibiotics are generally appropriate, and a backup culture is not routinely required for a positive rapid antigen test in children. If symptoms are atypical, the clinician may reassess. Antibiotics are not harmless: they can cause diarrhea and allergic reactions and contribute to resistance. The parent should also know that untreated true strep can rarely lead to rheumatic fever and that completing the prescribed course matters. Use plain language and teach-back. Document the discussion and the clinical findings, not just the test result.
3. The school nurse proposes using only the rapid test and not confirming negative results with culture. Evaluate this proposal.
Read the worked answer
Skipping backup culture for all negative rapid tests is not safe in this pediatric population. The test sensitivity is 92%, so about 7–8 of the 90 true cases would be missed per 300 children. Those children could develop suppurative complications or spread infection, and some may return with worse illness. Guidelines for children generally recommend confirming a negative rapid antigen test with culture or a molecular test, because children have higher rates of strep and complications.
A better policy: continue backup culture or molecular testing for negative rapid results, especially when clinical suspicion is high; use a shared decision rule for low-risk children; and track return visits and positive cultures. If resources are tight, the center could prioritize confirmation for children with fever, exudate, or household contact, but that is a compromise, not a blanket elimination. The $18 culture cost should be compared with the cost of missed cases, repeat visits, and antibiotic misuse. The nurse manager should involve the medical director and review local resistance and follow-up capacity.